DR. MARTIN MARKOWITZ, MD
Osteopathic Medicine in New York, NY
License number
New York 145826
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
455 Floor Aaron Diamond Aids Research Ctr, New York, NY 10016
Phone
(212) 448-5020
(212) 725-1126 (Fax)
(212) 725-1126 (Fax)
Personal information
See more information about MARTIN MARKOWITZ at radaris.comName
Address
Phone
80 Woodland Dr, Southampton, NY 11968
7 Peppermill Ct, Commack, NY 11725
7622 249Th St, Jamaica, NY 11426
525 E 86Th St, New York, NY 10028
525 E 86Th St APT 15H, New York, NY 10028
Organization information
See more information about MARTIN MARKOWITZ at bizstanding.comMartin Markowitz MD
455 1 Ave, New York, NY 10016
Industry:
Internist
Phone:
(212) 448-5020 (Phone)
Martin Harold Markowitz
Professional information
See more information about MARTIN MARKOWITZ at trustoria.com
Martin Harold Markowitz, New York NY
Martin Harold Markowitz, New York NY
Specialties:
Internist
Address:
455 1St Ave, New York, NY 10016
Education:
Stanford University, School of Medicine - Doctor of Medicine
New York Presbyterian Hospital/Weill Cornell Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)
UCSF Medical Center at Mount Zion - Residency - Family Medicine
New York Presbyterian Hospital/Weill Cornell Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)
UCSF Medical Center at Mount Zion - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Martin Harold Markowitz, New York NY
Martin Harold Markowitz, New York NY
Specialties:
Internal Medicine, Hematology, Medical Oncology, Infectious Disease
Work:
Aaron Diamond Aids Research Ct
455 1St Ave, New York, NY 10016
455 1St Ave, New York, NY 10016
Education:
Stanford University (1978)
Dr. Martin Markowitz, New York NY - MD (Doctor of Medicine)
Dr. Martin Markowitz, New York NY - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
AARON DIAMOND AIDS RESEARCH CENTER
455 1St Ave SUITE 7TH, New York 10016
(212) 725-0018 (Phone), (212) 725-1126 (Fax)
455 1St Ave SUITE 7TH, New York 10016
(212) 725-0018 (Phone), (212) 725-1126 (Fax)
Certifications:
Hematology, 1984, Internal Medicine, 1981, Medical Oncology, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Stanford University
Graduated: 1978
Mt Zion Hosp
Cornell Med Coll
Stanford University
Graduated: 1978
Mt Zion Hosp
Cornell Med Coll
Servant At City Of Brooklyn
Servant At City Of Brooklyn
Location:
Greater New York City Area
Industry:
Government Administration
Senior Associate Dean At Rutgers University
Senior Associate Dean At Rutgers University
Location:
Greater New York City Area
Industry:
Higher Education
Molecular Clone Of Hiv-1
Molecular Clone Of Hiv-1
US Patent:
2013017, Jul 11, 2013
Filed:
Mar 3, 2011
Appl. No.:
13/582319
Inventors:
George M. Shaw - Birmingham AL, US
Beatrice H. Hahn - Birmingham AL, US
Hui Li - Birmingham AL, US
Barton F. Haynes - Durham NC, US
Martin Markowitz - New York NY, US
Beatrice H. Hahn - Birmingham AL, US
Hui Li - Birmingham AL, US
Barton F. Haynes - Durham NC, US
Martin Markowitz - New York NY, US
Assignee:
Duke University - Durham NC
The UAB Research Foundation - Birmingham AL
The UAB Research Foundation - Birmingham AL
International Classification:
A61K 39/21
US Classification:
4241881, 530350, 536 2372, 4353201, 5303879, 4352351
Abstract:
The present invention relates, in general, to HIV-1 and, in particular, to a molecular clone of HIV-1. The invention further relates to methods of inducing an immune response to HIV-1 in a patient and to immunogens suitable for use in such methods. The invention also relates to anti-HIV-1 antibodies and to methods of using same to prevent or treat HIV-infection.
Protease Assay For Therapeutic Drug Monitoring
Protease Assay For Therapeutic Drug Monitoring
US Patent:
2005022, Oct 6, 2005
Filed:
Nov 8, 2002
Appl. No.:
10/494903
Inventors:
Sergei Gulnik - Frederick MD, US
Betty Yu - Frederick MD, US
John Erickson - Potomac MD, US
Martin Markowitz - New York NY, US
Betty Yu - Frederick MD, US
John Erickson - Potomac MD, US
Martin Markowitz - New York NY, US
International Classification:
C12Q001/70, C12M001/34
US Classification:
435005000, 435287200
Abstract:
The present invention concerns a further development and use of biological assays to determine the amount or concentration of an active ingredient present in a sample. The enzyme assay of the present invention determines the amount or concentration of protease inhibitors, including retroviral protease inhibitors such as HIV inhibitors.
Vaccination Of Hiv Infected Persons Following Highly Active Antiretrovial Therapy
Vaccination Of Hiv Infected Persons Following Highly Active Antiretrovial Therapy
US Patent:
2004003, Feb 19, 2004
Filed:
Oct 9, 2002
Appl. No.:
10/182067
Inventors:
David Ho - New York NY, US
Martin Markowitz - New York NY, US
MICHEL KLEIN - LYON CEDEX, FR
RAPHAELLE HABIB - LYON CEDEX, FR
Martin Markowitz - New York NY, US
MICHEL KLEIN - LYON CEDEX, FR
RAPHAELLE HABIB - LYON CEDEX, FR
International Classification:
C07H021/04, A61K031/70, A01N043/04, A61K039/21, C12N015/00, C12N015/09, C12N015/63, C12N015/70, C12N015/74
US Classification:
536/023720, 435/320100, 424/208100
Abstract:
The present invention provides a method of permitting cessation of antiviral therapy on HIV-infected subjects without virus rebound or with at least a delayed virus rebound or a decreased post rebound set-point. The method comprises the re-induction of HIV-specific immune responses using a vaccination strategy to induce both humoral and cell-mediated immunity. The present invention achieves an immunological control of persistent infectious virus after discontinuation of antiviral therapy. The vaccine strategy according to the invention is both safe and immunogenic in the subject HIV-infected patient population.